BLOG

Planning a Trip for Adipose Stem Cell Therapy in Osaka, Japan

Published 2026.10.08 7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

For many international patients, the hardest part of considering regenerative medicine in Japan is not the idea of the treatment itself but the logistics. Adipose-derived stem cell therapy is not a single appointment. It involves a consultation, a small fat collection, a period of cell culture at a specialized facility, and a later infusion. Grand Green Osaka Umekita Clinic provides this treatment in Osaka, and this article explains how to think about timing and travel before you decide anything.

Short answer: expect more than one step, and confirm the schedule with a doctor

The treatment is built around your own cells. A very small amount of fat tissue is collected, mesenchymal stem cells are cultured and expanded, and the cultured cells are returned to your body by IV infusion. Because culture takes time, collection and infusion cannot happen on the same day. The exact number of visits, the length of the culture period, and the overall timeline depend on your condition and the doctor’s judgment, so they should be confirmed during a consultation rather than assumed from general information online.

This is a self-pay treatment that is not covered by Japanese public health insurance. It is provided under Japan’s regenerative medicine regulations, including the Act on the Safety of Regenerative Medicine, and a treatment plan has to be prepared and submitted under that framework. Costs, risks, possible side effects, and whether the treatment is appropriate for you all need to be discussed with a physician.

Why the treatment is spread over separate stages

Mesenchymal stem cells are somatic stem cells found in fat tissue, bone marrow, and other tissues. Published research suggests they can secrete anti-inflammatory substances and growth factors, but the evidence varies by condition, and results in studies cannot be assumed to apply to every individual. Fat tissue is generally considered a richer source of these cells than bone marrow, and it can be collected through a small incision under local anesthesia. Only a few rice-grain-sized pieces are needed.

After collection, the cells are sent to a specialized facility where they are cultured and expanded. This stage is the main reason a trip needs planning. The cells need time to grow, and quality checks are part of the process. Rather than treating the waiting period as a delay, it is useful to see it as a normal part of preparing a personalized cell product.

What this means for your travel plans

Both fat collection and infusion are performed on an outpatient basis, so hospitalization is not part of the standard flow. That is helpful for work and family commitments, but it does not mean the process should be taken lightly. You may want to think about several practical points before booking flights.

Whether you could return to Japan for the infusion after the culture period, or whether a different arrangement is possible.
How you would rest after the collection procedure, and whether the doctor recommends avoiding certain activities or long flights afterward.
Whether your passport, visa status, and any entry requirements allow a stay of the length you may need.
How you would reach the clinic again if the schedule needs to change, for example because of a cold, fever, or other health change.

Because the schedule depends on medical judgment, it is best not to book non-refundable travel until the clinic has confirmed the timing in writing or through a clear consultation record.

Health information to prepare before you travel

The doctor will need an accurate picture of your health. If you can, gather your diagnoses, current medications, allergies, past surgeries, and recent test results, ideally in English or with a translation. If you are receiving standard treatment for a condition, tell the doctor. Stem cell therapy should not be understood as a replacement for standard medical care, and your existing treatment plan should not be changed without speaking to the physician who manages it.

Some conditions, such as infections, certain medical histories, or the use of particular medicines, may affect whether collection or infusion is appropriate. These are questions only a doctor can answer after an examination, and in some cases the answer may be that the treatment is not suitable.

Questions to ask at the consultation

A consultation is the right place to turn general information into a plan for you. Consider asking the following questions and writing down the answers so you can compare them later.

How many visits are expected, and how far apart will they be?
What are the known risks and possible side effects of collection and infusion?
What is included in the stated fee, and what could be charged separately?
What happens if the cultured cells cannot be used or the plan changes?
What follow-up is available once you return home, and in which language?

Grand Green Osaka Umekita Clinic is located in the Umeda area of Osaka, which is reachable by train from major transport hubs, and the clinic offers information pages for international patients. Consulting in advance through the available channels can help you understand the process before you commit to any travel.

Summary

Adipose-derived stem cell therapy follows a sequence of consultation, fat collection, cell culture, and infusion, and the culture period is why it cannot be completed in a single visit. Planning around that sequence, preparing your medical information, and asking clear questions about schedule, cost, and risk will help you make a calmer decision. Treatment effects differ between individuals and are not guaranteed, and the final decision should be made together with a doctor after a proper examination.

Typical Treatment Sequence

1ConsultationConfirm plan with doctor
2Fat collectionOutpatient, local anesthesia
3Cell cultureAt a specialized facility
4IV infusionOutpatient

This figure is a conceptual diagram that summarizes the article. Schedules should be confirmed with a doctor

Learn more about Adipose-Derived Stem Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to Adipose-Derived Stem Cell Therapy ›